News

In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully

Deloitte’s annual study of information security trends finds gaping holes in network security

Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations

IMS Health rolls out Global Message IQ service for syndicated market research

Apriso’s FlexNet software to help trace RFID-tagged plasma throughout supply chain

California pedigree delay proves fatal to pioneering IT firm

Biggest focus remains oncologic/immunologic and CNS drugs; about one in six candidates eventually gain approval, according to Tufts study

Approval marks an innovative buccal drug-delivery mechanism, as well as signaling how FDA might approach REMS for all opioids

Moisture control, time-temperature monitoring are among the application areas being driven by biotech products and others, says Freedonia Group

As it absorbs Genentech, Roche leaves PhRMA and joins BIO

Study is sponsored by IT vendor Axway

Companies collaborate on customized system tailored to the pharma supply chain

Advocacy group for compliance packaging want to build its membership

Consumers might get product recall information faster than healthcare professionals

Merrion Pharma announces good Phase II results at ASCO meeting

First decline since Armstrong & Associates began tracking the industry in 1996

Compliance jumps over last year’s top issue, competitive pressure, among healthcare supply-chain decisionmakers

New IDC study finds that Oracle is the now the top life-sciences IT vendor; meanwhile, are there ‘demons’ in the pharma supply chain?

The marketplace requirements for sales force structures are changing faster than the industry is evolving

Coming off a record-setting year, ABC stresses growth in generics, and services revolving around specialty pharmaceuticals

War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players

States pile on rules; industry wishes for consistency

Effective integration of a company’s contract strategy with operations can have a big impact on financial performance

Closely-watched negotiation removes some uncertainty for Cardinal as it spins out its CareFusion subsidiary

Antipsychotic and antidepressant drugs have risen to the top categories of prescribed medications in a challenging and risky medical and regulatory arena

While drug spending by clients averaged 3.3% last year, higher spending growth is predicted for the next three years

Evidence Generation Is the Foundation to Optimal Product Positioning

XStream Systems’ X-ray technology finds fakes in the returns stream